D305-1713 Screening compound: N-{1-butyl-2-[(morpholin-4-yl)methyl]-1H-1,3-benzodiazol-5-yl}-2-(4-methylphenoxy)acetamide

D305-1713 Screening compound: N-{1-butyl-2-[(morpholin-4-yl)methyl]-1H-1,3-benzodiazol-5-yl}-2-(4-methylphenoxy)acetamide
D305-1713 Screening compound: N-{1-butyl-2-[(morpholin-4-yl)methyl]-1H-1,3-benzodiazol-5-yl}-2-(4-methylphenoxy)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D305-1713
N-{1-butyl-2-[(morpholin-4-yl)methyl]-1H-1,3-benzodiazol-5-yl}-2-(4-methylphenoxy)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D305-1713

Molecular Formula

C25H32N4O3 (C25 H32 N4 O3)

Compound Name

N-{1-butyl-2-[(morpholin-4-yl)methyl]-1H-1,3-benzodiazol-5-yl}-2-(4-methylphenoxy)acetamide

IUPAC name

N-{1-butyl-2-[(morpholin-4-yl)methyl]-1H-13-benzodiazol-5-yl}-2-(4-methylphenoxy)acetamide

SMILES

CCCCn1c(ccc(NC(COc2ccc(C)cc2)=O)c2)c2nc1CN1CCOCC1

InChI

InChI=1S/C25H32N4O3/c1-3-4-11-29-23-10-7-20(26-25(30)18-32-21-8-5-19(2)6-9-21)16-22(23)27-24(29)17-28-12-14-31-15-13-28/h5-10,16H,3-4,11-15,17-18H2,1-2H3,(H,26,30)

InChI Key

RRPQZZMSQGRBHW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27579999

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

436.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.170

Distribution Coefficient, logD

4.165

Water Solubility, LogSw

-3.96

Polar Surface Area

53.411

Acid Dissociation Constant (pKa)

12.44

Base Dissociation Constant (pKb)

5.42

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

D305-1713 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with D305-1713 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D305-1713?
Check Price and Availability of D305-1713, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D305-1713 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D305-1713
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D305-1713
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D305-1713 available by request